comprehensive -WSS

comprehensive

author：explore 2025-09-27 23:01:26 - browse：96

Business standing in the middle of a maze near a bag with a dollar sign on it. -- biotech coverage from STAT — Adobe

Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists.

Representatives from pension funds, college endowments, family offices, and other organizations with money to invest have become bolder in their requests, according to interviews with a host of VCs. They’re pushing not only for advantageous terms in a VC firm’s latest fund, but in some cases, have angled for equity in the firm itself. These types of conditions aren’t unheard of, but have become more frequent as venture capitalists have a harder time raising funds, and as outside investors feel empowered to ask for more bang for their buck.

“A lot is changing in venture fundraising right now,” said Nan Li, co-founder and managing partner of Dimension, which launched last January. Outside investors tried to ask for a piece of Dimension, but the new firm had more than enough interest in its first fund and was able to turn down those proposals. Two other young VC firms told STAT they’ve fielded similar requests, and one investment group reported that it had managed to negotiate an equity stake in a VC firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Anavex keeps shifting the goalposts in its clinical trials

WSS

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Can food be medicine? And other questions about a new push

Friends ask where James Watson's attitudes about race came from

How to use technology to prevent future drug shortages

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

FDA panel issues narrow recommendation for Covid vaccine booster doses

hotspot

comprehensive

focus

Heart attack and stroke risk calculators need revising

Maui's cultural, historic landmarks damaged in the devastating wildfires

Novavax promises a turnaround & Lilly roils the obesity market

South Korea throws huge K

Psychedelics group wrestles with new pharma identity

Meta looks to target Twitter with a rival app called Threads

Duchenne breakthrough therapy leaves behind pioneering families

Doctor appointment wait times are getting worse

Hepatitis C has a cure — but many Americans still lack access to it

Brain 'hot spot' may explain why African Americans feel greater pain

entertainment

Australia's humpback populations rebound raising hopes of marine scientists

Wegovy trial has doctors encouraged over new possibilities

RaDonda Vaught case: a double standard for nurses, physicians

Make 'food is medicine' a key part of White House nutrition meeting

Grail is spending more than ever lobbying Congress

PhRMA sues HHS over Medicare drug price negotiation

Wikipedia

focus

hotspot

focus